Stay updated on Nivolumab+SAbR in Metastatic Clear Cell Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab+SAbR in Metastatic Clear Cell Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab+SAbR in Metastatic Clear Cell Renal Cell Carcinoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added, replacing the previous v3.4.2 label.
    Difference
    0.1%
    Check dated 2026-03-11T20:00:40.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and the previous government funding notice and Revision: v3.4.1 were removed.
    Difference
    0.4%
    Check dated 2026-02-11T05:20:26.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page now includes a site-wide notice about government funding and NIH operations, and the page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T05:22:47.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a Show glossary feature and updated the page revision to v3.4.0; capitalization tweaks were made to QC criteria wording and FEAR Act data, replacing the previous v3.3.4 text.
    Difference
    0.2%
    Check dated 2026-01-28T03:24:52.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision update: v3.3.4 added and v3.3.3 removed; no changes to study content or displayed data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:41:25.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a dedicated Locations section with Texas as the site and removed the prior Texas Locations entry. The page revision updated to v3.3.3 and the HHS Vulnerability Disclosure link was removed.
    Difference
    0.2%
    Check dated 2025-12-23T09:14:32.000Z thumbnail image

Stay in the know with updates to Nivolumab+SAbR in Metastatic Clear Cell Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab+SAbR in Metastatic Clear Cell Renal Cell Carcinoma Clinical Trial page.